Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Arch Gynecol Obstet ; 278(2): 173-6, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18214512

ABSTRACT

BACKGROUND: Despite the high incidence of candida vaginitis, intraamniotic candida infection seems to be a rare disease. This infective agent can cause chorioamnionitis even in the presence of intact fetal membranes. METHODS AND RESULTS: We report four new cases of intrauterine candidiasis and describe the associated clinicopathological features. Three of the cases had predisposing risk factors, like rupture of membranes or intrauterine contraceptive device, and ended in fetal death; the fourth case had a gestational trophoblastic disease. DISCUSSION: The pathogenic significance of fetal contamination by candida appears to depend largely on gestational age. Candida infection of the fetus can result in prematurity and death. The importance of early and accurate diagnosis of intraamniotic infection with candida is emphasized.


Subject(s)
Candidiasis/pathology , Chorioamnionitis/pathology , Gestational Trophoblastic Disease/pathology , Uterine Diseases/pathology , Adult , Female , Fetal Death , Humans , Pregnancy , Pregnancy Outcome
2.
Exp Hematol ; 27(2): 380-5, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10029178

ABSTRACT

Cost-efficient umbilical cord blood (UCB) banking requires well-standardized methods of volume reduction and storage. To compare UCB fractionation using a technique of hydroxyethyl starch (HES) sedimentation with the Ficoll (double) and Percoll methods, 50 whole units was allocated randomly to each procedure. HES resulted in a significantly better recovery of mononuclear cells (87.5%), granulocyte/macrophage colony-forming units (CFU-GM) (88.4%), and CD34- cells (87.4%) and lesser volume reduction (85.5%). HES was the least laborious, time consuming, and expensive of the three procedures, costing 3.4- and 4.4-fold less than the Ficoll and Percoll methods, respectively. Five units processed by each method was frozen in 4.5-mL cryotubes under optimal conditions. After thawing, the greatest degree of recovery of viable nucleated cells and number of CFU-GM per unit were obtained using the HES procedure. Using 4.5-mL cryotubes, the calculated number of units that could be stored in 600-L containers was 3.8- and 2.2-fold higher for Ficoll- and Percoll-separated than for HES-separated units, respectively. Nevertheless, the higher direct costs of the density gradient separation procedures outweighed their lower storage cost. For long-term cryopreservation, we assessed the freezing of HES-processed units in 50-mL cryobags and their specifically designed canisters. We found cell recoveries similar to those obtained with cryotubes, but storage capacity was decreased. Special racks designed for these canisters resulted in a 5-fold increase over the number of units stored in standard cryobags. This system also is feasible for Percoll- and Ficoll-separated units, resulting in comparable storage costs for the three separation methods. We conclude that this HES procedure and the 50-mL cryobags constitute a cost-efficient system for large-scale UCB banking.


Subject(s)
Blood Preservation/methods , Hematopoietic Stem Cell Mobilization/methods , Hematopoietic Stem Cell Transplantation , Cell Survival , Fetal Blood , Humans , Transplantation, Homologous
3.
Bone Marrow Transplant ; 21(11): 1097-9, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9645571

ABSTRACT

One of the concerns about the use of cord blood as a source of hematopoietic stem cells for allogeneic transplantation is the possibility of contamination by maternal cells which could cause life-threatening GVHD. We have assessed cord blood contamination using PCR analysis of several minisatellite regions to detect maternal DNA. Eighty mother-cord pairs were obtained for this study. In one case there were no specific maternal alleles at any loci and, therefore, cord blood could not be evaluated. Thus, there was a total of 79 informative cases for the detection of maternal cells in the fetal circulation. In most cases, the level of detection was between 0.5 and 1%. We detected maternal DNA in the cord blood sample in only one case (1.26%), and the analysis of dilution experiments led to an estimate of 0.5-1% maternal cells. In conclusion, using PCR amplification of hypervariable regions, maternal DNA is very rarely detected in the cord blood collected at birth, although this approach has a relatively low level of sensitivity.


Subject(s)
DNA/blood , DNA/genetics , Fetal Blood/chemistry , Minisatellite Repeats , Polymerase Chain Reaction/methods , Chimera/genetics , Chimera/immunology , Female , Fetal Blood/cytology , Genotype , Graft vs Host Disease/etiology , Hematopoietic Stem Cell Transplantation/adverse effects , Humans , Infant, Newborn , Maternal-Fetal Exchange/genetics , Maternal-Fetal Exchange/immunology , Polymerase Chain Reaction/statistics & numerical data , Pregnancy , Sensitivity and Specificity , Transplantation, Homologous
SELECTION OF CITATIONS
SEARCH DETAIL
...